Ponesimod
id:
ponesimod-265-10105760
title:
Ponesimod
text:
Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis. It is a sphingosine-1-phosphate receptor modulator. The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension. Ponesimod was approved for medical use in the United States in March 2021, and in the European Union in June 2021.
brand slug:
wiki
category slug:
encyclopedia
description:
Medication for the treatment of multiple sclerosis
original url:
https://en.wikipedia.org/wiki/Ponesimod
date created:
date modified:
2024-03-26T05:36:15Z
main entity:
{"identifier":"Q18604129","url":"https://www.wikidata.org/entity/Q18604129"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fd/Ponesimod.svg","width":512,"height":428}
fields total:
13
integrity:
15